Table 1 Health impact summary for infants and children of age 1–5, by stunting status
From: Evaluating the cost-effectiveness of preventive zinc supplementation
Baseline | Optimistic scenario | Pessimistic scenario | ||||
|---|---|---|---|---|---|---|
Health impact for stunted children ages 1- 5 | ||||||
Risk reduction: Diarrhea | 0.87 | Yakoob [9] | 0.73 | Brown [13] | 0.91 | Patel [32] |
Risk reduction: ALRI | 0.86 | Roth [28] | 0.81 | Yakoob [9] | 0.94 | Roth [28] |
Risk reduction: Child mortality | 0.82 | Brown [13] | 0.82 | Brown [13] | 0.94 | Brown [13] |
Health impact for non- stunted children ages 1- 5 | ||||||
Risk reduction: Diarrhea | 1 | Brown [13] | 0.73 | Brown [13] | 1 | Brown [13] |
Risk reduction: ALRI | 0.86 | Roth [23] | 0.81 | Yakoob [27] | 1 | Lower limit |
Risk reduction: Child mortality | 0.82 | Brown [8] | 0.82 | Brown [8] | 0.94 | Brown [8] |
Health impact for stunted infants (Age 0– 11 months) | ||||||
Risk reduction: Diarrhea | 1 | 1 | Brown [13] | 1 | ||
Risk reduction: ALRI | 1 | Gulani [6] | 0.81 | Yakoob [9] | 1 | Lower limit |
Risk reduction: Child mortality | 1 | Brown [13] | 0.91 | 1 | Brown [13] | |
Health impact for non- stunted infants (Age 0– 11 months) | ||||||
Risk reduction: Diarrhea | 1 | 1 | Brown [13] | 1 | ||
Risk reduction: ALRI | 1 | Gulani [6] | 0.81 | Yakoob [9] | 1 | Lower limit |
Risk reduction: Child mortality | 1 | Brown [13] | 0.91 | 1 | Brown [13] | |